Faced with an epidemic of drug abuse and overdose deaths, the FDA has proposed a Risk Evaluation and Mitigation Strategy for prescription opioid pain relievers, involving improved education for physicians and patients about risks associated with long-acting opioids.
No takes yet. Share an insight, caveat, or question.
Susan Okie (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: